ESRX - Express Scripts Holding Company

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
95.03
-1.61 (-1.67%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close96.64
Open97.21
Bid0.00 x 1800
Ask0.00 x 1000
Day's Range94.53 - 97.73
52 Week Range66.93 - 101.73
Volume6,044,176
Avg. Volume4,195,396
Market Cap53.559B
Beta (3Y Monthly)0.94
PE Ratio (TTM)11.00
EPS (TTM)8.64
Earnings DateFeb 25, 2019 - Mar 1, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date2003-11-12
1y Target Est93.37
Trade prices are not sourced from all markets
  • ACCESSWIRE18 hours ago

    Today's Research Reports on Trending Tickers: Centene and Express Scripts Holding

    NEW YORK, NY / ACCESSWIRE / December 18, 2018 / U.S. equities extended losses on Monday as investors await details from the Federal Reserve's final policy meeting of 2018 on Wednesday. The Dow Jones Industrial ...

  • Zacks2 days ago

    Here's Why You Should Buy Express Scripts (ESRX) Stock Now

    Strong demand for Express Scripts' (ESRX) solutions like SafeGuardRx, 90-day supply for chronic medications, exclusive Accredo Specialty Pharmacy and advanced opioid solutions buoy optimism.

  • Argentiere Capital’s Returns, AUM and Holdings
    Insider Monkey3 days ago

    Argentiere Capital’s Returns, AUM and Holdings

    Deepak Gulati‘s Argentiere Capital is a Zug, Switzerland-based hedge fund launched back in June 2013, with an additional office in Chicago. The fund is focused on offering its services to pooled investment vehicles and manages separate client-focused equity portfolios. It’s run by a team of former members of JP Morgan’s Global Equities Proprietary Trading Group […]

  • Only one state stands in the way of $54B Cigna/Express Scripts deal
    American City Business Journals5 days ago

    Only one state stands in the way of $54B Cigna/Express Scripts deal

    Only one state stands in the way of approving the $54 billion merger between Cigna and Express Scripts after government authorities in California and New York signed off on the deal Thursday. Both California's Department of Managed Health Care and New York's Department of Financial Services approved the deal and listed a set of conditions the companies agreed to. Conditions to the transaction in California Conditions to the transaction in New York Per the California approval, Cigna and Express Scripts agree to not increase premiums as a result of acquisition costs, and keep premium rate increases to a minimum.

  • Is Express Scripts Holding (ESRX) Stock Outpacing Its Medical Peers This Year?
    Zacks5 days ago

    Is Express Scripts Holding (ESRX) Stock Outpacing Its Medical Peers This Year?

    Is (ESRX) Outperforming Other Medical Stocks This Year?

  • Zacks5 days ago

    Express Scripts Announces 3-Year Agreement With Walmart

    Express Scripts (ESRX) and Walmart (WMT) collaborate to increase affordable access of the expensive prescription drugs for insured and uninsured patients.

  • Dealmaker Patrick Nolan on St. Louis’ big year in M&A
    American City Business Journals6 days ago

    Dealmaker Patrick Nolan on St. Louis’ big year in M&A

    St. Louis has had a blockbuster year in mergers and acquisitions, though two big company headquarters — Monsanto Co. and Express Scripts Holding Co. — are being lost in the process.

  • The Wall Street Journal6 days ago

    [$$] Walmart, Express Scripts Extend Prescription-Services Agreement

    Retail giant Walmart Inc. and pharmacy-benefit manager Express Scripts Holding Co. have extended their network agreement to provide access to Walmart’s prescription services for Express Scripts clients’ covered members. The three-year agreement will help both insured and uninsured customers save money on prescription drugs, the companies said Wednesday. Walmart also will participate in Express Scripts’s pharmacy-savings program called InsideRx, which provides discounts, on average of 40%, to uninsured Americans using brand-name prescription drugs.

  • Walmart & Express Scripts extend deal, McDonald's serves up changes, CBS settles lawsuit
    Yahoo Finance7 days ago

    Walmart & Express Scripts extend deal, McDonald's serves up changes, CBS settles lawsuit

    Walmart, McDonald's, CBS, Credit Suisse and Dave & Buster's are the companies to watch.

  • MarketWatch7 days ago

    Walmart and Express Scripts to offer cheaper meds to uninsured and underinsured Americans

    Shares of Walmart Inc. and Express Scripts Holding Co. rose in premarket trade Wednesday, after the two announced a three-year agreement to provide cheaper medications to underinsured and uninsured Americans. Walmart will have access to Express Scripts' lower pricing on dozens of brand-name prescription drugs. The pharmacy benefits manager will offer its InsideRx, which provides discounts of an average of 40% to uninsured customers on brand-name prescription drugs. Express Scripts shares rose 1.2% premarket and have gained 29% in 2018, while the S&P 500 has fallen 1.4%.

  • PR Newswire7 days ago

    Walmart and Express Scripts Sign Three-Year Agreement to Deliver Greater Value to Insured and Uninsured Pharmacy Customers

    BENTONVILLE, Ark. and ST. LOUIS, Dec. 12, 2018 /PRNewswire/ -- Today, Walmart and Express Scripts (ESRX) announced an extension to the companies' existing network agreement to provide access to Walmart's prescription services for Express Scripts clients' covered members.  The companies also made a commitment to deliver additional affordable prescription solutions to millions of underinsured and uninsured Americans. As part of the ongoing relationship, Walmart is partnering with Express Scripts' to access their unique pricing on dozens of brand-name prescription drugs, and create additional value for its customers. As one example, Express Scripts has introduced a novel solution – InsideRx -- to provide discounts, on average 40%, to uninsured Americans on a growing number of important brand-name prescription drugs.

  • See what the IHS Markit Score report has to say about Express Scripts Holding Co.
    Markit8 days ago

    See what the IHS Markit Score report has to say about Express Scripts Holding Co.

    Express Scripts Holding Co NASDAQ/NGS:ESRX

  • Barrons.com8 days ago

    Tired of Stock Market Volatility? It’s Been a Good Year to Bet on Mergers.

    “Merger arbitrage” funds buy shares of a target company in a publicly announced acquisition, and short the stocks of the acquiring company.

  • ESRX vs. HQY: Which Stock Is the Better Value Option?
    Zacks13 days ago

    ESRX vs. HQY: Which Stock Is the Better Value Option?

    ESRX vs. HQY: Which Stock Is the Better Value Option?

  • CNW Group13 days ago

    Express Scripts Names Dr. Dorian Lo as President of Express Scripts Canada; Michael Biskey to retire in First Quarter 2019

    Express Scripts Names Dr. Dorian Lo as President of Express Scripts Canada; Michael Biskey to retire in First Quarter 2019

  • CVS Hears Trump, But Don't Count on Lower Drug Prices
    Bloomberg13 days ago

    CVS Hears Trump, But Don't Count on Lower Drug Prices

    The company announced a new pricing model for its pharmacy benefit management services Wednesday morning. The White House has been an active critic of PBMs, which negotiate drug discounts on behalf of employers and health plans, arguing that they have distorted the drug-pricing system. Drugmakers pay rebates than can amount to more than 50 percent of a drug’s sticker price to secure favorable coverage on PBM drug lists, and critics contend that firms like CVS keep an excessive slice of those undisclosed payments.

  • Should Value Investors Buy Express Scripts (ESRX) Stock?
    Zacks14 days ago

    Should Value Investors Buy Express Scripts (ESRX) Stock?

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

  • Express Scripts (ESRX) Soars to 52-Week High, Time to Cash Out?
    Zacks14 days ago

    Express Scripts (ESRX) Soars to 52-Week High, Time to Cash Out?

    Express Scripts (ESRX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

  • Express Scripts (ESRX) Hits 52-Week High, Can the Run Continue?
    Zacks14 days ago

    Express Scripts (ESRX) Hits 52-Week High, Can the Run Continue?

    Express Scripts (ESRX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

  • See what the IHS Markit Score report has to say about Express Scripts Holding Co.
    Markit15 days ago

    See what the IHS Markit Score report has to say about Express Scripts Holding Co.

    Express Scripts Holding Co NASDAQ/NGS:ESRX

  • Zacks15 days ago

    Stocks Jump 1% on 90-Day Tariff Delay

    Stocks Jump 1% on 90-Day Tariff Delay

  • 6 Companies Growing Earnings
    GuruFocus.com15 days ago

    6 Companies Growing Earnings

    The earnings per share of Express Scripts Holding Co. (ESRX) have grown 34% annually over the last five years. According to the DCF calculator, the stock is undervalued and is trading with a 50% margin of safety at $101 per share. The price-earnings ratio is 11.85.

  • George Soros Bought These 2 Healthcare Stocks in the Third Quarter
    Motley Fool16 days ago

    George Soros Bought These 2 Healthcare Stocks in the Third Quarter

    The Soros Fund Management bought shares of both Express Scripts and Zai Lab Limited during the third quarter.

  • Express Scripts Holding Stock Has Risen 36% in 2018
    Market Realist16 days ago

    Express Scripts Holding Stock Has Risen 36% in 2018

    On November 29, Express Scripts Holding’s (ESRX) stock price closed at $101.22, which is ~5% growth from the close of $96.81 on November 23. Express Scripts Holding’s stock price grew from $74.64 at the close of the market on December 29, 2017, to $101.22 at the close of the market on November 29, which reflects ~36% YTD (year-to-date) growth.

  • How to Invest in Global Wide Moat Stocks
    Market Realist18 days ago

    How to Invest in Global Wide Moat Stocks

    The strength displayed by the U.S. Moat Index in October was not only a result of its underweighting to tech stocks. Strong stock selection within the communication services and consumer discretionary sectors provided a significant boost for the U.S. Moat Index, along with an advantageous overweight to consumer staples stocks and underweight to energy and industrials stocks.